advertisement
Bunce C 149
Showing records 1 to 25 | Display only abstracts from Bunce C in IGR 21-3105797 Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
Gazzard G; Konstantakopoulou E; Garway-Heath D; Adeleke M; Vickerstaff V; Ambler G; Hunter R; Bunce C; Nathwani N; Barton K;
Ophthalmology 2023; 130: 139-151 (IGR: 23-3)
96041 Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma: An Overview of Cochrane Systematic Reviews and Network Meta-analysis
Bicket AK; Le JT; Azuara-Blanco A; Gazzard G; Wormald R; Bunce C; Hu K; Jayaram H; King A; Otárola F; Nikita E; Shah A; Stead R; Tóth M; Li T
JAMA ophthalmology 2021; 139: 983-989 (IGR: 22-3)
94591 Ab interno supraciliary microstent surgery for open-angle glaucoma
Sandhu A; Jayaram H; Hu K; Bunce C; Gazzard G
Cochrane Database of Systematic Reviews 2021; 5: CD012802 (IGR: 22-2)
92189 Ab interno trabecular bypass surgery with Trabectome for open-angle glaucoma
Hu K; Shah A; Virgili G; Bunce C; Gazzard G
Cochrane Database of Systematic Reviews 2021; 2: CD011693 (IGR: 22-1)
91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Founti P; Bunce C; Khawaja AP; Doré CJ; Mohamed-Noriega J; Garway-Heath DF;
Ophthalmology 2020; 127: 1642-1651 (IGR: 21-4)
90631 Corneal Endothelial Cell Loss after Baerveldt Glaucoma Implant Surgery
Hau S; Bunce C; Barton K
Ophthalmology. Glaucoma 2021; 4: 20-31 (IGR: 21-3)
86368 Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma
Otarola F; Virgili G; Shah A; Hu K; Bunce C; Gazzard G
Cochrane Database of Systematic Reviews 2020; 3: CD012740 (IGR: 21-2)
82879 Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial
Garg A; Vickerstaff V; Nathwani N; Garway-Heath D; Konstantakopoulou E; Ambler G; Bunce C; Wormald R; Barton K; Gazzard G;
Ophthalmology 2020; 127: 467-476 (IGR: 20-4)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Garg A
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gazzard G
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Gazzard G
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Konstantakopoulou E
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Vickerstaff V
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Konstantakopoulou E
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garway-Heath D
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Garway-Heath D
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Nathwani N
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Garg A
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Garway-Heath D
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garg A; Vickerstaff V
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Vickerstaff V
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Konstantakopoulou E
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Hunter R
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Hunter R
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Ambler G
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)